BARDA
US biodefence agency partnering on Artemis II's organ-on-chip radiation experiments.
Last refreshed: 2 April 2026 · Appears in 1 active topic
Why is a biodefence agency involved in a Moon mission?
Timeline for BARDA
Mentioned in: No approved Ebola drug works on Bundibugyo
Pandemics and BiosecurityMentioned in: Crew's Own Cells Fly to the Moon as Living Experiments
Artemis II Moon MissionBackground
BARDA is a partner on the AVATAR organ-on-chip experiment aboard Orion, contributing biodefence expertise to deep-space radiation research on the first crewed lunar flight since Apollo.
The Biomedical Advanced Research and Development Authority is part of the US Department of Health and Human Services. Normally focused on medical countermeasures for chemical, biological, radiological, and nuclear threats, BARDA funds the development of vaccines, therapeutics, and diagnostics for public health emergencies.
BARDA's involvement reflects the dual-use Nature of the AVATAR technology. Radiation response data gathered from crew-specific organ chips in deep space has direct applications in BARDA's terrestrial mandate: understanding how ionising radiation damages human tissue at the cellular level informs both space medicine and radiological countermeasure development.
What is BARDA and why is it involved in Artemis II?
What does BARDA normally do?
How does space radiation research benefit biodefence?
Who else is involved in the AVATAR experiment?
Written with AI from Lowdown's published reporting. Not individually reviewed by an editor. Updated 2 April 2026. Editorial standards.